These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 12623954)

  • 1. Low-density lipoprotein subfractions and cardiovascular risk in hypertension: relationship to endothelial dysfunction and effects of treatment.
    Felmeden DC; Spencer CG; Blann AD; Beevers DG; Lip GY
    Hypertension; 2003 Mar; 41(3):528-33. PubMed ID: 12623954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of flow-mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension: relationship to cardiovascular risk and effects of treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Felmeden DC; Blann AD; Spencer CG; Beevers DG; Lip GY
    Blood Coagul Fibrinolysis; 2003 Jul; 14(5):425-31. PubMed ID: 12851527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of lipid profile and high blood pressure on endothelial damage.
    Sugiura T; Dohi Y; Yamashita S; Yamamoto K; Wakamatsu Y; Tanaka S; Kimura G
    J Clin Lipidol; 2011; 5(6):460-6. PubMed ID: 22108149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of acute trans-resveratrol supplementation in treated hypertensive patients with endothelial dysfunction.
    Marques BCAA; Trindade M; Aquino JCF; Cunha AR; Gismondi RO; Neves MF; Oigman W
    Clin Exp Hypertens; 2018; 40(3):218-223. PubMed ID: 29431520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.
    Oravec S; Dostal E; Dukát A; Gavorník P; Kucera M; Gruber K
    Neuro Endocrinol Lett; 2011; 32(4):502-9. PubMed ID: 21876506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the association between flow-mediated dilation and cardiovascular risk limited to low-risk populations?
    Witte DR; Westerink J; de Koning EJ; van der Graaf Y; Grobbee DE; Bots ML
    J Am Coll Cardiol; 2005 Jun; 45(12):1987-93. PubMed ID: 15963397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired endothelial function in hypertensive elderly patients evaluated by high resolution ultrasonography.
    Kimura Y; Matsumoto M; Den YB; Iwai K; Munehira J; Hattori H; Hoshino T; Yamada K; Kawanishi K; Tsuchiya H
    Can J Cardiol; 1999 May; 15(5):563-8. PubMed ID: 10350666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size.
    Tani S; Matsumoto M; Nagao K; Hirayama A
    J Cardiol; 2014 Jan; 63(1):60-8. PubMed ID: 24016623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT]).
    Felmeden DC; Spencer CG; Chung NA; Belgore FM; Blann AD; Beevers DG; Lip GY
    Am J Cardiol; 2003 Aug; 92(4):400-5. PubMed ID: 12914869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of hypertension with small, dense low-density lipoprotein in patients without metabolic syndrome.
    Kim YK; Seo HS; Lee EM; Na JO; Choi CU; Lim HE; Kim EJ; Rha SW; Park CG; Oh DJ
    J Hum Hypertens; 2012 Nov; 26(11):670-6. PubMed ID: 21975689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endothelial function in high risk cardiovascular patients].
    Káli A; Jánosi A
    Orv Hetil; 2006 Jan; 147(3):99-106. PubMed ID: 16515028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of endothelial dysfunction, lipid metabolism in women with polycystic ovary syndrome: relationship of paraoxonase 1 activity, malondialdehyde levels, low-density lipoprotein subfractions, and endothelial dysfunction.
    Bayram F; Kocer D; Ozsan M; Muhtaroglu S
    Gynecol Endocrinol; 2012 Jul; 28(7):497-501. PubMed ID: 22703625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of low density lipoprotein (LDL) subfraction profile and LDL oxidation on endothelium-dependent and independent vasodilation in patients with type 2 diabetes.
    Tan KC; Ai VH; Chow WS; Chau MT; Leong L; Lam KS
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3212-6. PubMed ID: 10487689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced endothelial progenitor cells and brachial artery flow-mediated dilation as evidence of endothelial dysfunction in ocular hypertension and primary open-angle glaucoma.
    Fadini GP; Pagano C; Baesso I; Kotsafti O; Doro D; de Kreutzenberg SV; Avogaro A; Agostini C; Dorigo MT
    Acta Ophthalmol; 2010 Feb; 88(1):135-41. PubMed ID: 19549102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired flow-mediated vasodilation in type 2 diabetes: lack of relation to microvascular dysfunction.
    Meyer MF; Lieps D; Schatz H; Pfohl M
    Microvasc Res; 2008 May; 76(1):61-5. PubMed ID: 18448131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effects after withdrawal of simvastatin on brachial artery endothelial function in patient with coronary heart disease or risk factors].
    Chen H; Ren JY; Wu B; Liu X; Wang RJ; Li LJ; Luo Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jun; 35(6):531-5. PubMed ID: 17711713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease.
    Shechter M; Issachar A; Marai I; Koren-Morag N; Freinark D; Shahar Y; Shechter A; Feinberg MS
    Int J Cardiol; 2009 May; 134(1):52-8. PubMed ID: 18479768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vasomotor endothelial dysfunction in young men with grade 1 arterial hypertension].
    Zairova AR; Oshchepkova EV; Rogoza AN
    Kardiologiia; 2013; 53(7):24-30. PubMed ID: 24087956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The time course of flow-mediated vasodilation and endothelial dysfunction in patients with a cardiovascular risk factor.
    Kabutoya T; Hoshide S; Ogata Y; Iwata T; Eguchi K; Kario K
    J Am Soc Hypertens; 2012; 6(2):109-16. PubMed ID: 22321961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women.
    El-Magadmi M; Bodill H; Ahmad Y; Durrington PN; Mackness M; Walker M; Bernstein RM; Bruce IN
    Circulation; 2004 Jul; 110(4):399-404. PubMed ID: 15262847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.